The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. EVERSANA commercialization expert, Amy Hutnik answers an important question every manufacturer needs to know about omnichannel:
How does EVERSANA’s omnichannel activation model go “beyond marketing” to elevate multi-stakeholder engagement?